Floatz logo

IMMUNOGLOBULIN G4, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .KAPPA.-CHAIN, DIMER

Gastric Adenocarcinoma

Eli Lilly and Companymonoclonal_antibodyPhase 1/2Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
73/ 100

Competitive context

65 Active assets in the Gastric Adenocarcinoma cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Boehringer Ingelheim
Phase 3BB
Capecitabine
Shanghai Zhongshan Hospital
Phase 3BB
TRASTUZUMAB
Boehringer Ingelheim
Phase 2BB
CIS-DIAMMINEDICHLOROPLATINUM II
Mayo Clinic
Phase 3BB
Eloxatin
Shanghai Zhongshan Hospital
Phase 3BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G4, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .KAPPA.-CHAIN, DIMER is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
65 / 100
View asset →
hepatocellular carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →
gastroesophageal junction adenocarcinomaDormant
CC
Indicative ·
46 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →